Iceland· IS-910225

Livostin

A levocabastine product containing levocabastinum inn hýdróklóríð, registered in Iceland by McNeil Sweden AB. The same ATC class is registered in 10 of our 19 countries.

ATC R01AC02

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedLivostinATCR01AC02REGISTER NO.IS-910225PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Levocabastine is registered in 10 of 19 countries.

Countries holding a registration under ATC R01AC02 (levocabastine), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 6 of them publish a price we can compare per daily dose

Levocabastine · ATC R01AC02

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Levocabastinum INN hýdróklóríð
Manufacturer
McNeil Sweden AB
Country
Iceland (IS)
ATC code
R01AC02
ATC class
Levocabastine
Defined daily dose
0.6 mg, N
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Levocabastine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All levocabastine products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Levocamed, Livostin
  • Belgium · Livostin, Nasasinuspray Anti-Allergie
  • Czechia · Livostin
  • Germany · Levocabastin, Levocamed
  • Denmark · Benaliv
  • Spain · Bilina, Reactine
  • Finland · Livostin
  • France · Allergiflash, Levofree
  • Greece · Livostin
  • Italy · Levoreact, Levoreact Oftalmico
  • Luxembourg · Livostin, Nasasinuspray Anti-Allergie
  • Netherlands · Livocab
  • Norway · Livostin
  • Sweden · Livostin
  • Slovakia · Livostin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/124d6a64-e631-42f7-ac20-498705467116
GET /v1/drugs/124d6a64-e631-42f7-ac20-498705467116?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Nefúði, dreifa",
  "source": "lyfjastofnun",
  "atc_raw": "R01AC02",
  "marketed": true,
  "strength": "50 míkróg/skammt",
  "ma_number": "910225",
  "substance": "Levocabastinum INN hýdróklóríð",
  "other_info": "Heimilt er að selja takmarkað magn lyfsins í lausasölu sbr. pakkningu merkta L. Mest 30 ml  handa einstaklingi.",
  "legal_status": "(L R) Ekki lyfseðilsskylt/ lyfseðilsskylt",
  "ma_issued_serial": "34151"
}

See everything about levocabastine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.